Position in AZN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$388,910
New position
Shares Held
2,051
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#945
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rosenberg Matthew Hamilton holds $5,886,852 across 15 Drug Manufacturers - General names. AZN ranks #7 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,135 | $1,040,531 | |
| 2 | JNJ |
Johnson & Johnson
|
3,924 | $996,578 | |
| 3 | LLY |
ELI LILLY & Co
|
748 | $897,173 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,672 | $728,852 | |
| 5 | AMGN |
Amgen Inc
|
1,419 | $513,848 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,450 | $435,873 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
2,051 | $388,910 | |
| 8 | NVO |
Novo Nordisk A S
|
5,989 | $287,112 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $388,910 | 2,051 | Shares | Sole | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||